News & Updates

The direct oral anticoagulants (DOACs) apixaban and rivaroxaban trump warfarin for the treatment of venous thromboembolism (VTE) in a retrospective observational analysis comprising real-world VTE patients from Finland, Norway, and Sweden.

A French study presented at EULAR 2024 reveals an association between statin treatment and an increased risk of total joint replacement in individuals with knee and hip osteoarthritis (OA).

Statins are effective for primary prevention of cardiovascular disease (CVD) and all-cause mortality in individuals aged 75–84 and ≥85 years, and are not associated with significantly increased risks of myopathies and liver dysfunction, according to a target trial emulation conducted using real-world territory-wide electronic health records in Hong Kong.

Erectile dysfunction (ED) is independently associated with a higher risk of major adverse cardiovascular events (MACE), suggests a study. Moreover, rural men appear to be at greater risk of MACE, with an even higher risk among those with an ED diagnosis.

In the CAST-HF trial, the addition of direct cardiac shockwave therapy (SWT) to coronary artery bypass graft (CABG) surgery improves left ventricular ejection fraction (LVEF) and physical capacity in individuals with ischaemic heart failure (IHF).